Literature DB >> 8383526

Human chemotaxis receptor genes cluster at 19q13.3-13.4. Characterization of the human C5a receptor gene.

N P Gerard1, L Bao, H Xiao-Ping, R L Eddy, T B Shows, C Gerard.   

Abstract

The human C5a anaphylatoxin and formyl peptide receptor genes, as well as two genes with high sequence identity to the formyl peptide receptor, FPRH1 and FPRH2, have been mapped to chromosome 19 (Lu et al., 1992). Further analysis reveals that these genes are present in the 19q13.3 band adjacent to the 13.3-13.4 interface. MRNAs for the C5a and formyl peptide receptors, as well as for FPRH1, are expressed in cAMP differentiated U937 cells and human eosinophils, while all four transcripts are expressed in human lung. This observation opens the possibility for coordinate regulation of these genes. In order to initiate the mapping of fine structure at this locus, genomic clones have been analyzed. All four of the genes have a similar structure, with the receptor protein encoded in a single exon. Detailed characterization of the C5a receptor gene reveals a two exon structure, with the 5' untranslated sequence and initiating methionine located in the first exon. An intron of approximately 9 kb separates exon 1 from the receptor-encoding exon 2. The region of genomic DNA flanking the 5' untranslated sequence possesses promoter activity when transfected into the myeloid-derived rat basophilic leukemia RBL-1 cells, but the same region is inactive when transfected into nonmyeloid cells. Deletional analyses indicate that C5a receptor 5' flanking region contains both cell-specific suppressor and promoter regions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383526     DOI: 10.1021/bi00056a007

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Pharmacological characterization of antagonists of the C5a receptor.

Authors:  N J Paczkowski; A M Finch; J B Whitmore; A J Short; A K Wong; P N Monk; S A Cain; D P Fairlie; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

2.  Response-selective C5a agonists: differential effects on neutropenia and hypotension in the rat.

Authors:  A J Short; N J Paczkowski; S M Vogen; S D Sanderson; S M Taylor
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

3.  Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit.

Authors:  D R Bachvarov; S Houle; M Bachvarova; J Bouthillier; S A St-Pierre; Y Fukuoka; J A Ember; F Marceau
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Cloning and functional characterization of the human fractalkine receptor promoter regions.

Authors:  Alexandre Garin; Philippe Pellet; Philippe Deterre; Patrice Debré; Christophe Combadière
Journal:  Biochem J       Date:  2002-12-15       Impact factor: 3.857

5.  Functional roles for C5a and C5aR but not C5L2 in the pathogenesis of human and experimental cerebral malaria.

Authors:  Hani Kim; Laura K Erdman; Ziyue Lu; Lena Serghides; Kathleen Zhong; Aggrey Dhabangi; Charles Musoke; Craig Gerard; Christine Cserti-Gazdewich; W Conrad Liles; Kevin C Kain
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

6.  Prolonged elevation of intracellular cyclic AMP levels in U937 cells increases the number of receptors for and the responses to formylmethionyl-leucylphenylalanine, independently of the differentiation process.

Authors:  T Fischer; R Zumbihl; J Armand; P Casellas; B Rouot
Journal:  Biochem J       Date:  1995-11-01       Impact factor: 3.857

Review 7.  Function, structure and therapeutic potential of complement C5a receptors.

Authors:  P N Monk; A-M Scola; P Madala; D P Fairlie
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

Review 8.  Transcriptional control of complement receptor gene expression.

Authors:  Brian K Martin
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

9.  Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.

Authors:  P D Ponath; S Qin; T W Post; J Wang; L Wu; N P Gerard; W Newman; C Gerard; C R Mackay
Journal:  J Exp Med       Date:  1996-06-01       Impact factor: 14.307

10.  Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor.

Authors:  J L Gao; E J Lee; P M Murphy
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.